Safety and tolerability of intramuscular sotrovimab administered at different injection sites: results from the Phase 1 COSMIC study.

ABSTRACT:

Trial registration

ClinicalTrials.gov identifier, NCT05280717.

SUBMITTER: Moore J 

PROVIDER: S-EPMC11784644 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature